iRhythm Technologies, Inc. (NASDAQ:IRTC) Q2 2020 Earnings Highlights Kevin King – President, CEO & Director “As we entered the second quarter, we faced many uncertainties related to the impact of COVID-19 and that would have […]
Pfizer Inc. and BioNTech SE disclosed “positive” data from an early trial of their BNT162b2 mRNA-based vaccine candidate against SARS-CoV2 and confirmed that they were on track to seek regulatory review as early as October.The news drove BioNTech (BNTX) shares up 10% on Friday, while Pfizer rose less than 1% at the close of day.Pfizer (PFE) and BioNTech shared additional Phase 1 safety and immunogenicity data from their ongoing US study of the BNT162 mRNA-based vaccine program against Covid-19.The newly released data shows key safety and immunogenicity data from the US Phase 1 trial for the BNT162b2 vaccine candidate, which …read more […]
Rates on 30-year loans are as low as 1.999%. Here are four tips for getting a good deal. …read more […]
Americans pay various types of taxes and discuss taxes in routine conversations. But how many people really know what basic terms and concepts mean? …read more […]
2020 will be remembered as the year of the biotech sector. Amid the ongoing pandemic, biotech stocks have taken center stage, with the names developing COVID-19 solutions being catapulted to remarkable highs. But, after posting such jaw-dropping gains, where do these stocks go from here? Morgan Stanley’s Chief U.S. Equity Strategist Mike Wilson says the story could get even better. Doubling down on his optimistic stance, he argues stimulus packages that support consumer demand as well as cost-cutting measures could be catalysts that spur strong showings in 2021. “We think that a return of topline growth and a material reduction …read more […]
The stock market has been soaring after tumbling for the first several weeks of the pandemic. Should you be worried that another crash is coming? …read more […]
The housing market entered the COVID-19 pandemic from a place of strength thanks to favorable supply/demand technicals and house-hunting millennials. …read more […]
Out on Wall Street, some stocks are shooting for the stars. Driven by optimism related to a COVID-19 vaccine, swift Federal Reserve action as well as better-than-expected economic data, the market has bounced back with sheer force since hitting a low point five months ago. Not only has the S&P 500 recovered its COVID-induced losses, but it has gone on to break a record, reaching a new closing high on August 21. So, is there more growth on tap for stocks? For some, the answer is yes. According to the analyst community, a few names reflect serious growth plays. …read more […]
Tesla Inc. is seeking approval to market a short-range interactive motion sensor device that would help prevent kids from being left in hot cars and improve theft-prevention systems.Tesla (TSLA) has filed a request with the Federal Communications Commission asking for permission to market the device, which would operate at a higher power level than allowed under current rules. The device, which would be integrated in passenger vehicle interiors, incorporates millimeter wave (mmWave) radar technology to detect movements within a vehicle and to classify vehicle occupants.The electric vehicle maker argues that for the full potential of this life-saving technology, the sensor …read more […]
After seeing some strength earlier on, biotech stocks came under pressure in the week ended Aug. 21. With the earnings season tapering and not much of noise on the coronavirus front, the sector reacted to some clinical readouts, two M&A announcements and a couple of adverse rulings handed down by the FDA.Three biotech issues IPOed this week, collecting a cumulative $404.1 in gross proceeds. This apart, Israeli medical imaging startup Nano-X Imaging Ltd (NASDAQ: NNOX) raised $165.2 million.Here’re the key catalysts for the unfolding week:ConferencesVirtual World Orphan Drug Congress USA 2020: Aug. 24-27 European Association for the …read more […]
Retail industry observers say Simon Property Group, the largest owner and manager of U.S. malls, is well suited to turn around trouble retailers. …read more […]
Gilead Sciences Inc. could be granted additional emergency use authorization by US regulators for its drug remdesivir to include patients hospitalized with moderate COVID-19, despite recent mixed trial results, the company’s top research executive told Reuters on Friday.Data published by Gilead (GILD) on Friday showed that a 5-day course of intravenous remdesivir modestly helped less severely ill COVID-19 patients, but a 10-day course did not show a benefit.Back in May, the US Food and Drug Administration (FDA) approved sales of remdesivir on an emergency basis for patients hospitalized with severe COVID-19, the disease caused by the new coronavirus, after trial …read more […]
Susquehanna lifted Keysight Technologies’ price target to $132 (37.7% upside potential) from $130 and reiterated a Buy rating on the stock as the electronic design and test solutions provider is poised to benefit from 5G deployments.Susquehanna analyst Mehdi Hosseini wrote in a note to investors on Aug. 21 that Keysight Technologies (KEYS) is likely to “benefit from continued 5G/400G roll out in APAC and US despite weaker EU.” Hosseini said that “We are increasing our FWD PE valuation multiple from 21x to 22x to account for the increased sustainability of the 5G and higher speed Networking investment cycle, all while …read more […]
I am a huge Elon Musk fan and believe Tesla will likely become the next Apple or Amazon. However, at its current valuation, a 50%+ collapse in the stock price seems inevitable. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
